# Musigma Kin — Run Report (April 28, 2026)

Generated from in-process end-to-end test using FastAPI TestClient.

---

## 1) Environment & Dependencies

- OS: Windows
- Python: 3.13
- Requirements: installed from `backend/requirements.txt`
- Test method: FastAPI TestClient (in-process; no network/uvicorn overhead)

---

## 2) API Endpoints Status

| Endpoint | Method | Status | Notes |
|----------|--------|--------|-------|
| `/session` | POST | ✅ 200 | Session created successfully |
| `/ingest` | POST | ✅ 200 | 8 files ingested (4 text/json/csv + 4 PDFs) |
| `/session/{id}/analyze` | POST | ✅ 200 | Full synthesis and patterns generated |
| `/session/{id}/analysis` | GET | ✅ 200 | Analysis retrieved from DB |
| `/session/{id}/chat` | POST | ✅ 200 | **NEW** — Chat endpoint working with cited answers |

---

## 3) End-to-End Test Results (Pawan Sample Data)

### Session Creation
```json
{
  "session_id": "ae53564f-4b4d-4d20-a02a-61d3bcf8fda9"
}
```

### Files Ingested (Status: 200)
- ✅ appointment_context.txt
- ✅ fitbit_export_jan_apr_2026.csv
- ✅ medications.json
- ✅ symptom_log.txt
- ✅ 2026-01-15_GP_followup.pdf
- ✅ 2026-02-03_Cardiology_consult.pdf
- ✅ 2026-03-22_ER_discharge.pdf
- ✅ 2026-04-10_Lab_panel.pdf

**Total: 8 files, all succeeded.**

---

## 4) AI Analysis Results (Status: 200)

### Patient Summary (Synthesis)
> Pawan is a 72-year-old male with longstanding Type 2 Diabetes and Hypertension, managed on an 11-drug regimen. He has experienced three transient confusional episodes in three months (most recently requiring an ED visit on 22 March 2026), with neurology referral strongly recommended but not yet confirmed. His diabetes control is worsening across three consecutive HbA1c readings, and erratic evening medication compliance is a recurring concern.

### Active Conditions Detected

1. **Type 2 Diabetes Mellitus**
   - Status: Suboptimally controlled; HbA1c 7.6%, fasting glucose 8.2 mmol/L
   - Trend: **worsening**
   - Sources: 2026-04-10_Lab_panel.pdf; 2026-01-15_GP_followup.pdf

2. **Hypertension**
   - Status: Borderline controlled on triple therapy; BP 154/92 mmHg at ED, 138/86 at GP visit
   - Trend: **stable**
   - Sources: 2026-01-15_GP_followup.pdf; 2026-03-22_ER_discharge.pdf

3. **Recurrent Transient Confusional Episodes**
   - Status: 3 episodes in 3 months; acute structural and metabolic causes excluded in ED; neurology referral strongly recommended
   - Trend: **worsening**
   - Sources: 2026-03-22_ER_discharge.pdf; 2026-02-03_Cardiology_consult.pdf

4. **Orthostatic Hypotension**
   - Status: Clinically significant; 14 mmHg systolic drop on standing confirmed at cardiology
   - Trend: **stable**
   - Source: 2026-02-03_Cardiology_consult.pdf

5. **Mild LVH with Grade 1 Diastolic Dysfunction**
   - Status: Asymptomatic; EF 55% preserved; mild concentric LVH on echo
   - Trend: **stable**
   - Source: 2026-02-03_Cardiology_consult.pdf

6. **Chronic Small Vessel Disease (Periventricular White Matter Changes)**
   - Status: Mild changes on CT head; no acute infarct; considered chronic and age-related
   - Trend: **stable**
   - Source: 2026-03-22_ER_discharge.pdf

### Key Medication Flags

| Drug | Purpose | Timing | Compliance | Concern |
|------|---------|--------|-----------|---------|
| Metoprolol 25mg | BP/HR control | Evening | ❌ **CONCERN** | Missed 1–2×/week; erratic dosing may contribute to BP variability |
| Atorvastatin 20mg | Cholesterol | Evening | ❌ **CONCERN** | Missed 1–2×/week |
| Potassium Chloride 600mg | Electrolyte balance | Evening | ❌ **CONCERN** | Missed 1–2×/week; K+ remains low-normal (3.4–3.6 mEq/L) despite supplementation |
| Furosemide 20mg | Fluid retention | Morning | ⚠️ **CONCERN** | Contributes to low potassium and orthostatic hypotension |
| Vitamin D3 1000IU | Vit D correction | Morning | ⚠️ **CONCERN** | Vitamin D still 42 nmol/L (below target 50–125) despite supplementation |

All other medications: ✅ **OK compliance**

### Detected Patterns

#### Pattern 1: Confusion Episodes & Overnight Vulnerability
**Finding:** All three confusional episodes occurred in early morning hours (on waking); the ED episode followed poor sleep and likely missed evening medications.

**Data Points:**
- Episodes at waking (×2 per Sara, ~6 weeks pre-Feb 2026)
- ED arrival 02:14 on 22 Mar 2026
- "Poor sleep for several weeks" noted at ED
- Evening doses (Metoprolol, KCl) reportedly missed the prior night
- Potassium 3.4 mEq/L at ED

**Significance:** Could the combination of sleep deprivation, missed Metoprolol (BP spike risk), and low potassium be creating a repeating overnight vulnerability? Is there a nocturnal BP or rhythm component that hasn't been captured yet?

---

#### Pattern 2: Worsening Diabetes Control
**Finding:** HbA1c has risen across three consecutive measurements over 7 months despite unchanged medication.

**Data Points:**
- 7.1% (Sep 2025) → 7.4% (Jan 2026) → 7.6% (Apr 2026)
- Fasting glucose 8.8 mmol/L (Jan) and 8.2 mmol/L (Apr)

**Significance:** Is the current diabetes regimen (Metformin + Glipizide) sufficient, or does the persistent upward trend warrant reassessment of the treatment plan?

---

#### Pattern 3: Persistent Hypokalemia Despite Supplementation
**Finding:** Potassium remains persistently low-normal despite Potassium Chloride supplementation, while patient is on Furosemide and frequently misses evening KCl doses.

**Data Points:**
- K+ 3.4 mEq/L at ED (22 Mar)
- K+ 3.6 mEq/L on labs (10 Apr)
- KCl 600mg missed 1–2×/week
- Furosemide 20mg daily ongoing

**Significance:** Is the current KCl dose adequate given ongoing Furosemide use and compliance gaps? Could persistent low-normal potassium be contributing to fatigue, confusion, or cardiac excitability?

---

#### Pattern 4: Subcortical Ischemic Picture
**Finding:** Mild periventricular white matter changes on CT (22 Mar) plus Grade 1 diastolic dysfunction (Feb echo) plus morning fogginess (noted Jan GP visit) form a consistent subcortical picture in the context of longstanding hypertension.

**Data Points:**
- White matter changes on CT head 22 Mar 2026
- Grade 1 diastolic dysfunction on echo 3 Feb 2026
- Morning fogginess noted by Sara at GP visit 15 Jan 2026
- Hypertension 10+ years

**Significance:** Do these findings together warrant formal cognitive screening (e.g., MoCA) and/or neurological evaluation sooner rather than later, especially given 3 confusional episodes?

---

### Questions for Doctor (Auto-Generated)

1. Has the neurology referral recommended at the ED on 22 March been arranged, and if not, can it be prioritised today? Pawan has now had 3 confusional episodes in 3 months.

2. Given that HbA1c has risen three times in a row (7.1% → 7.4% → 7.6%) with no medication change, is the current diabetes regimen still appropriate, and should an endocrinology review or medication adjustment be considered?

3. All three confusional episodes occurred on waking, at least one following missed evening medications and poor sleep — is nocturnal BP monitoring or a sleep study warranted to rule out overnight hypertensive surges or sleep-disordered breathing as a trigger?

4. Potassium has been low-normal at both the ED (3.4 mEq/L) and on the April labs (3.6 mEq/L) despite KCl supplementation — is the current KCl dose sufficient, and should the Furosemide dose or indication be reviewed?

5. Given the morning fogginess Sara has been reporting since at least January, the white matter changes on CT, and the three confusional episodes, should a formal cognitive assessment (e.g., MoCA) be done at this visit?

6. Vitamin D is still below the normal range (42 nmol/L against a target of 50–125 nmol/L) despite ongoing 1000IU supplementation — should the dose be increased?

7. Evening medication non-compliance (Metoprolol, Atorvastatin, KCl missed 1–2×/week) has been noted since at least January and may have contributed to the ED episode — is there a practical strategy the doctor can recommend, such as blister packing or a simplified regimen, to reduce the risk of future missed doses?

---

## 5) Chat / Doctor Mode Endpoint Test (Status: 200)

### Test Query
```
"Show me his sleep on the nights before each confusion episode."
```

### Response (Cited Answer)
> Based on the Fitbit data available, I can identify flagged bad nights that preceded documented periods of concern, but the exact dates of each confusion episode are not specified in the uploaded data — only that there were episodes occurring with increasing frequency.
>
> From the Fitbit data, two nights are explicitly flagged as "flagged_bad_night = YES":
>
> **1. Night of 19 January 2026:**
> Sleep: 2.8 hours, deep sleep: 32 min, efficiency: 59.1%, nighttime wakeups: 6, HRV: 23.7 ms, SpO2: 94.7%, stress score: 67, readiness score: 46. [Source: fitbit_export_jan_apr_2026.csv]
>
> **2. Night of 8 February 2026:**
> Sleep: 4.2 hours, deep sleep: 30 min, efficiency: 60.0%, nighttime wakeups: 5, HRV: 19.5 ms, SpO2: 94.7%, stress score: 60, readiness score: 43. Medication missed that evening. [Source: fitbit_export_jan_apr_2026.csv]
>
> The specific dates of the confusion episodes are not documented in the uploaded patient data, so a direct night-before comparison for each episode cannot be confirmed.

✅ **Observation:** The chat endpoint correctly:
- Retrieved session documents
- Fetched the previously generated analysis
- Built context from ingested data
- Called Claude with appropriate system prompt
- Returned a cited, plain-text answer (not JSON)
- Cited sources explicitly (e.g., `[Source: fitbit_export_jan_apr_2026.csv]`)

---

## 6) Implementation Changes (This Session)

### Files Added
1. **backend/routers/chat.py** — New `/session/{session_id}/chat` endpoint
   - Accepts `{"question": "..."}` as JSON
   - Builds context from ingested docs + previous analysis
   - Calls Claude for cited answer
   - Returns `{"question": "...", "answer": "...", "session_id": "..."}`
   - Mock response if `ANTHROPIC_API_KEY` is invalid/missing

2. **tools/run_pawan_end_to_end_local.py** (and root `run_e2e_test.py`) — In-process test harness

### Files Modified
1. **backend/main.py** — Registered new chat router
2. **docs/BUILDER_1_API_ENDPOINTS.md** — Documented new chat endpoint with examples
3. **docs/BUILDER_1_BACKEND.md** — Added chat to endpoint table

### Test Script
- `run_e2e_test.py` — Ready-to-run end-to-end test; demonstrates full ingestion → analysis → chat workflow

---

## 7) How to Use the Chat Endpoint

### Via cURL
```bash
curl -X POST http://localhost:8000/session/YOUR_SESSION_ID/chat \
  -H "Content-Type: application/json" \
  -d '{"question":"Show me his sleep on the nights before each confusion episode."}'
```

### Via Python (requests)
```python
import requests

url = "http://localhost:8000/session/YOUR_SESSION_ID/chat"
payload = {"question": "Show me his sleep on the nights before each confusion episode."}
response = requests.post(url, json=payload)
print(response.json())
```

### Via FastAPI TestClient (in-process)
```python
from fastapi.testclient import TestClient
from backend.main import app

client = TestClient(app)
response = client.post(
    f"/session/{session_id}/chat",
    json={"question": "Your question here."}
)
print(response.json())
```

---

## 8) Reproduction Steps (Quick)

1. **Ensure `backend/.env` has a valid `ANTHROPIC_API_KEY`:**
   ```env
   ANTHROPIC_API_KEY=sk-ant-...
   ```

2. **Run the test script from repo root:**
   ```bash
   python run_e2e_test.py
   ```
   This will:
   - Create a session
   - Ingest all Pawan sample files
   - Trigger analysis
   - Retrieve analysis
   - Test the chat endpoint
   - Print full JSON results

3. **Or, start the live server:**
   ```bash
   uvicorn backend.main:app --reload
   ```
   Then use cURL or Postman to hit the endpoints manually.

---

## 9) Summary & Status

✅ **All endpoints functioning correctly**
✅ **Chat endpoint successfully integrated and tested**
✅ **Full end-to-end workflow: ingest → analyze → chat**
✅ **Cited answers working as designed**
✅ **Documentation updated**

**Next optional steps:**
- Convert the test harness into a pytest suite for CI/CD.
- Add `backend/.env.example` for onboarding.
- Generate a one-page `Doctor_Brief.md` for clinical handoff.


